Methods for the analysis of leukemic infiltration within cerebrospinal fluid in acute lymphoblastic leukemia-a systematic review.

IF 2.2 4区 医学 Q3 HEMATOLOGY
Lavleen Singh, Kanika Rastogi, Amitabh Singh, Shraddhanjali Sathapathy, Venkateswaran K Iyer, Deepali Jain, Rachna Seth
{"title":"Methods for the analysis of leukemic infiltration within cerebrospinal fluid in acute lymphoblastic leukemia-a systematic review.","authors":"Lavleen Singh, Kanika Rastogi, Amitabh Singh, Shraddhanjali Sathapathy, Venkateswaran K Iyer, Deepali Jain, Rachna Seth","doi":"10.1080/10428194.2025.2550580","DOIUrl":null,"url":null,"abstract":"<p><p>Central nervous system (CNS) involvement in acute lymphoblastic leukemia (ALL) is associated with a poor prognosis, making its accurate detection vital for treatment planning. This systematic review critically examines the role of conventional cytomorphology (CC) and multiparameter flow cytometry (FC) in analyzing cerebrospinal fluid in acute lymphoblastic leukemia cases. While CC remains the gold standard, its sensitivity is limited, particularly in cases with low cell counts. FC offers greater sensitivity in identifying cases of 'occult' CNS disease (FC+/CC-). Pre-analytical variables, such as CSF volume, processing time, and preservation techniques, also influence the accuracy of both methods. Despite the advantages of FC, challenges remain, including the lack of standardized positivity criteria and unclear prognostic implications and management strategies for occult CNS disease (FC+ and CC-). Future research is needed to establish uniform diagnostic guidelines and to assess the clinical relevance of occult CNS disease in ALL.</p>","PeriodicalId":18047,"journal":{"name":"Leukemia & Lymphoma","volume":" ","pages":"1-13"},"PeriodicalIF":2.2000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leukemia & Lymphoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10428194.2025.2550580","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Central nervous system (CNS) involvement in acute lymphoblastic leukemia (ALL) is associated with a poor prognosis, making its accurate detection vital for treatment planning. This systematic review critically examines the role of conventional cytomorphology (CC) and multiparameter flow cytometry (FC) in analyzing cerebrospinal fluid in acute lymphoblastic leukemia cases. While CC remains the gold standard, its sensitivity is limited, particularly in cases with low cell counts. FC offers greater sensitivity in identifying cases of 'occult' CNS disease (FC+/CC-). Pre-analytical variables, such as CSF volume, processing time, and preservation techniques, also influence the accuracy of both methods. Despite the advantages of FC, challenges remain, including the lack of standardized positivity criteria and unclear prognostic implications and management strategies for occult CNS disease (FC+ and CC-). Future research is needed to establish uniform diagnostic guidelines and to assess the clinical relevance of occult CNS disease in ALL.

急性淋巴细胞白血病脑脊液白血病浸润分析方法综述。
急性淋巴细胞白血病(ALL)的中枢神经系统(CNS)受累与预后不良有关,因此其准确检测对治疗计划至关重要。本系统综述批判性地探讨了常规细胞形态学(CC)和多参数流式细胞术(FC)在分析急性淋巴细胞白血病病例脑脊液中的作用。虽然CC仍然是金标准,但其灵敏度有限,特别是在细胞计数低的情况下。FC在识别“隐匿性”中枢神经系统疾病(FC+/CC-)时具有更高的敏感性。分析前变量,如脑脊液体积、处理时间和保存技术,也会影响两种方法的准确性。尽管FC具有优势,但挑战仍然存在,包括缺乏标准化的阳性标准,对隐匿性中枢神经系统疾病(FC+和CC-)的预后影响和管理策略不明确。未来的研究需要建立统一的诊断指南,并评估ALL隐匿性中枢神经系统疾病的临床相关性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Leukemia & Lymphoma
Leukemia & Lymphoma 医学-血液学
CiteScore
4.10
自引率
3.80%
发文量
384
审稿时长
1.8 months
期刊介绍: Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信